Massive Bio Completes SOC 2 Type 1 Certification for Its AI Enabled Oncology Technology Platforms Including Patient Centric Clinical Trial Matching and Enrollment Services - Business Wire

- May 19, 2020
Massive Bio Completes SOC 2 Type 1 Certification for Its AI Enabled Oncology Technology Platforms Including Patient Centric Clinical Trial Matching and Enrollment Services - Business Wire

Massive Bio Completes SOC 2 Type 1 Certification for Its AI Enabled Oncology Technology Platforms Including Patient Centric Clinical Trial Matching and Enrollment Services  Business Wire